Little Green Pharma Ltd. (AU:LGP) has released an update.
Little Green Pharma Ltd. reports a solid financial performance with a 12% year-over-year revenue increase to $7.3 million and a 19% rise in cash receipts to $8.2 million. The company highlights strong sales growth in its CherryCo products and a significant uptick in oil and vaporizer sales, including an expansion into the French market. Future growth is anticipated with the development of new brands and the promising results from their psychedelic medicine clinical trials.
For further insights into AU:LGP stock, check out TipRanks’ Stock Analysis page.